Communicable Diseases: Clinical Trials

1,911 trials for Communicable Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1549 completed, 112 terminated, 80 unknown, 54 recruiting. 1911 Phase 1, 329 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11911Completed 1549, Terminated 112, Unknown 80, Recruiting 54, Withdrawn 51, Active not recruiting 32, Not yet recruiting 27, Enrolling by invitation 4, Suspended 2
Phase 2329Completed 223, Terminated 30, Unknown 23, Recruiting 17, Withdrawn 14, Not yet recruiting 12, Active not recruiting 10

Follow Communicable Diseases: new trials by email Literature Review of Communicable Diseases trials Research Report on Communicable Diseases

Trials (filtered) newest first · largest first

All 1,911 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected
426c.Mod.Core-C4b, 3M-052-AF, Aluminum hydroxide suspension (Alum) - HIV Infections
Phase 1Not yet recruitingHIV Vaccine Trials Network222027-03-302026-09-18
Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs
ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma
Phase 1 / Phase 2Not yet recruitingAbramson Cancer Center at Penn Medicine352027-01-312026-10-27
A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)
AVIHepC1, Normal Saline - Hepatitis C
Phase 1Not yet recruitingUniversity of Alberta272027-01-152026-09-25
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
VPM1002 Vaccine, BCG Vaccine, Placebo - Tuberculosis, HIV Infections
Phase 1 / Phase 2WithdrawnInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group2026-12-312026-08-17
Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV
Dose Level 1 ACU-D1 ointment, Dose Level 2 ACU-D1 ointment, Dose Level 3 ACU-D1 ointment - Human Papilloma Virus, Human Immunodeficiency Virus
Phase 1Not yet recruitingEmory University92026-12-012026-08-18
Mass Balance and Absolute Bioavailability of [14C]-VH4011499
VH4011499, [14C]-VH4011499 (IV), [14C]-VH4011499 (oral) - HIV Infections
Phase 1Not yet recruitingViiV Healthcare182026-11-092026-11-13
A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult Participants Without HIV
VH5356136 Formulation 1, VH5356136 Formulation 2, Placebo for VH5356136 Formulation 1 - HIV Infections
Phase 1Not yet recruitingViiV Healthcare1602026-11-062026-09-16
A Study to Compare Blood Levels of Bepirovirsen and Safety Using Different Methods of Injecting in Healthy Adult Participants
Bepirovirsen - Hepatitis B
Phase 1Not yet recruitingGlaxoSmithKline982026-11-032026-10-29
Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine
10vHPV, Gardasil9 - Human Papillomavirus Infection
Phase 1 / Phase 2Not yet recruitingSerum Institute of India Pvt. Ltd.722026-11-012026-11-06
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
AHB-137, Placebo, TVAX-008 - Chronic Hepatitis B
Phase 1 / Phase 2Not yet recruitingAusper Biopharma Co., Ltd.1052026-10-312026-10-19
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
AHB-137, TVAX-008, Placebo - Chronic Hepatitis B
Phase 1 / Phase 2Not yet recruitingGrand Theravac Life Sciences (Hangzhou) Co., Ltd.1052026-10-312026-10-27
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B
ACT500 Tablets, ACT500 Placebo Tablets - Metabolic Dysfunction-associated Steatotic Liver Disease, Chronic Hepatitis b
Phase 1Not yet recruitingXiamen Amoytop Biotech Co., Ltd.242026-10-302026-09-14
A Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) Participants
AHB-121, Placebo - Chronic Hepatitis B Virus
Phase 1Not yet recruitingAusper Biopharma Co., Ltd.1102026-10-282026-10-21
A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult Participants Without HIV
VIR-1388, Placebo - Cytomegalovirus (CMV), HIV (Human Immunodeficiency Virus)
Phase 1Not yet recruitingNational Institute of Allergy and Infectious Diseases (NIAID)122026-10-152026-09-03
Phase Ia/Ib Trial of SCTA02A Injection in Healthy Adults and Patients With Chronic Hepatitis B
SCTA02A, Placebo - Hepatitis B
Phase 1Not yet recruitingSinocelltech Ltd.602026-10-012026-10-29
A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in Healthy Adult Participants
VH4367310, Placebo - HIV Infections
Phase 1RecruitingViiV Healthcare1122026-09-152026-10-20
A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
WGc0201 - Chronic Hepatitis B Virus (Hbv)
Phase 1RecruitingJiyan Liu92026-09-012026-07-01
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)
MK-8527, Rifampin - Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
Phase 1Not yet recruitingMerck Sharp & Dohme LLC142026-09-012026-08-03
Safety and Immunogenicity of HPV Vaccine in HIV-infected
HPV vaccination - HIV-infected Individuals
Phase 1 / Phase 2Not yet recruitingBeijing 302 Hospital802026-09-012026-09-01
Precision Microbiota Interventions for Senoreduction Trial
Limosilactobacillus reuteri, Blueberry extract - HIV Infections, Alcohol Drinking
Phase 1 / Phase 2RecruitingLouisiana State University Health Sciences Center in New Orleans1602026-09-012026-10-29

Showing 20 of 1911. Sign in to see all of them.

Narrower conditions

HIV Infections (999)  ·  Acquired Immunodeficiency Syndrome (508)  ·  Hepatitis C (266)  ·  Hepatitis B, Chronic (146)  ·  Hepatitis B (106)  ·  Hepatitis C, Chronic (105)  ·  AIDS-Related Complex (102)  ·  Infections (94)  ·  Papillomavirus Infections (36)  ·  Sarcoma, Kaposi (32)  ·  Virus Diseases (30)  ·  Sexually Transmitted Diseases (25)  ·  AIDS-Related Opportunistic Infections (22)  ·  Hepatitis (22)

Broader conditions

Virus Diseases (1832)  ·  Infections (1817)  ·  Blood-Borne Infections (1797)  ·  RNA Virus Infections (1589)  ·  Urogenital Diseases (1342)  ·  Genital Diseases (1337)  ·  Sexually Transmitted Diseases (1311)  ·  Sexually Transmitted Diseases, Viral (1307)  ·  Immune System Diseases (1265)  ·  Lentivirus Infections (1256)  ·  Retroviridae Infections (1256)  ·  Immunologic Deficiency Syndromes (1255)  ·  Digestive System Diseases (576)  ·  Hepatitis, Viral, Human (550)

Interventions

Ritonavir (85)  ·  Zidovudine (68)  ·  Tenofovir (37)  ·  dolutegravir (37)  ·  Ribavirin (34)  ·  Didanosine (29)  ·  Lamivudine (29)  ·  Nevirapine (26)  ·  Raltegravir Potassium (26)  ·  Simeprevir (26)  ·  efavirenz (24)  ·  Darunavir (23)  ·  peginterferon alfa-2a (23)  ·  cabotegravir (22)  ·  entecavir (22)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (435)  ·  ViiV Healthcare (125)  ·  Merck Sharp & Dohme LLC (63)  ·  Bristol-Myers Squibb (49)  ·  GlaxoSmithKline (46)  ·  Tibotec Pharmaceuticals, Ireland (39)  ·  Gilead Sciences (32)  ·  National Cancer Institute (NCI) (30)  ·  Boehringer Ingelheim (25)  ·  Hoffmann-La Roche (22)  ·  International AIDS Vaccine Initiative (22)  ·  International Partnership for Microbicides, Inc. (21)  ·  Abbott (15)  ·  Pfizer (14)  ·  Radboud University Medical Center (13)

Countries

United States (1120)  ·  China (114)  ·  United Kingdom (97)  ·  Puerto Rico (74)  ·  New Zealand (68)  ·  South Africa (67)  ·  Australia (51)  ·  Germany (51)  ·  Thailand (48)  ·  Belgium (47)  ·  France (46)  ·  South Korea (44)  ·  Canada (40)  ·  Netherlands (39)  ·  Hong Kong (35)

Top investigators

Belshe R (9)  ·  Pablo Tebas, MD (8)  ·  Corey L (7)  ·  Marina Caskey, MD (7)

Results publications

PMID 40190112, PMID 25820067, PMID 23349878, PMID 34817414, PMID 34843602, PMID 22288567, PMID 32838558, PMID 34895272, PMID 16148846, PMID 16220994, PMID 18090046, PMID 19118378, PMID 21488067, PMID 22242162, PMID 22336878, PMID 22900504, PMID 22914365, PMID 25114140, PMID 25296098, PMID 26332605, PMID 27098021, PMID 27257978, PMID 27535056, PMID 30412360, PMID 30625297, PMID 31694954, PMID 31999736, PMID 33317695, PMID 34099325, PMID 35315687, PMID 37290591, PMID 38628675, PMID 39324693, PMID 41830320, PMID 42550463, PMID 42731017, PMID 10601506, PMID 10655111, PMID 10954886, PMID 11069252, PMID 11372025, PMID 11807307, PMID 11880966, PMID 11927734, PMID 12237598, PMID 12537512, PMID 12631091, PMID 12869836, PMID 14571185, PMID 14657758

NIH funding

2009 (13), U01CA121947 (11), 2015 (9), 2008 (8), 2017 (7), 2019 (7), 2014 (6), 2018 (6), UM1CA121947 (6), 2016 (5), 2023 (4), UM1AI068614 (4), 2005 (3), 2025 (3), P30CA015704 (2)